[Fetal hydantoin syndrome].
D000328:Adult; D000927:Anticonvulsants / Q000009:adverse effects* / Q000627:therapeutic use; D002648:Child; D002972:Cleft Palate / Q000139:chemically induced; D003394:Craniofacial Dysostosis / Q000139:chemically induced*; D004431:Ear, External / Q000002:abnormalities; D004827:Epilepsy / Q000188:drug therapy; D005260:Female; D006130:Growth Disorders / Q000139:chemically induced; D006801:Humans; D006972:Hypertelorism / Q000139:chemically induced*; D007223:Infant; D007231:Infant, Newborn; D008607:Intellectual Disability / Q000139:chemically induced*; D008297:Male; D008431:Maternal-Fetal Exchange; D011247:Pregnancy; D011248:Pregnancy Complications / Q000188:drug therapy; D013577:Syndrome
D000927:Anticonvulsants
Fetální hydantoinový syndrom.